With regard to South Korea, Novartis resolved particular well-publicized allegations that it experienced made improper payments to HCPs in South Korea through round tables and third-celebration health-related journals. Novartis Korea allegedly transmitted poor honoraria to HCPs for round tables as a result of clinical journals in order to avoid com